EPIEN Medical, Inc. (EPMI)

EPIEN Medical was planning to go public, but the IPO was withdrawn on Mar 21, 2023.
IPO Price Range
$4.25 - $6.25
Shares Offered
Deal Size
Chart not available yet
Data will show when the stock starts trading.
Market Cap 74.13M
Revenue (ttm) 1.27M
Net Income (ttm) -3.80M
Shares Out 14.12M
EPS (ttm) -0.27
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open n/a
Previous Close n/a
Day's Range n/a
52-Week Range n/a
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About EPMI

EPIEN Medical is a specialty medical devices company that is developing products for treatment of oral inflammation and acute and chronic wounds based on our chemical formulations that act as aggressive desiccation and debriding agents. We refer to this proprietary process as Desiccation Shock Technology (“DST”). Eleven published clinical trials have shown that our products reduce and, very often, eliminate the need for antibiotics to treat topical infectious wounds, including oral infections and open infectious wounds. Standard treatments can ... [Read more]

Industry Health Care
Sector Health Care Equipment & Supplies
Founded 1991
Employees 13
Stock Exchange NASDAQ
Ticker Symbol EPMI
Full Company Profile

Financial Performance

Financial Statements


EPIEN Medical IPO Registration Document (S-1)

EPIEN Medical has filed to go public with an IPO on the NASDAQ.

1 year ago - SEC